CD8A and melanoma: To be specific, compared to normal dermal fibroblasts, melanoma-associated fibroblasts (MAF) displayed increased activity of L-arginase, the selective inhibition of which could neutralize MAF-induced TIGIT and BTLA expression on CTLs and result in the activation of CD8+T cells and antitumor immunity (134).